We successfully represented Renal Care Group, Inc., in FCA litigation against the United States concerning allegations of billing for dialysis supplies. The opinion by the United States Court of Appeals for the Sixth Circuit in this action, reserving the district court and entering summary judgment on behalf of Renal Care and against the United States, is a key FCA ruling on the issues of falsity, knowledge, and materiality. U.S. ex rel. Williams v. Renal Care Group, Inc., 696 F.3d 518 (6th Cir. 2012).
Renal Care Group, Inc. (formerly NYSE: RCI) was a dialysis service provider that was acquired by Fresenius Medical Care AG (NYSE: FMS, FMS-p) in May 2005.